Journal of Inherited Metabolic Disease

, Volume 7, Issue 1, pp 41–45 | Cite as

Biochemical and clinical changes in Wilson's disease heterozygotes

  • Z. Mareček
  • S. Nevšímalová
Article

Abstract

This paper reports on a study of the heterozygous children of patients with Wilson's disease. A total of 16 children of 10 patients with the disease were followed up. Detailed biochemical, clinical and EEG tests were done. Nearly all the children were found to have reduced serum copper and caeruloplasmin levels and high rates of urine copper excretion following exposure to penicillamine. These findings were different from the results obtained in adult heterozygous carriers. Thirty per cent of the children had pathological neurological findings, and EEG abnormalities were found in 75%.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bearn, A. G. Wilson's disease. InThe Metabolic Basis of Inherited Diseases. McGraw Hill, New York, 1972Google Scholar
  2. Boulding, J. E. Treatment of Wilson's disease withd-penicillamine. In Walshe, J. M. and Cumings, J. N. (eds.)Wilson's Disease, Blackwell, Oxford, 1961Google Scholar
  3. Cox, D. W., Aspirin, N. and Sass-Kortsk, A. The metabolism of copper-67 in atypical heterozygotes for Wilson's disease.3rd Int. Symp. on Wilson's disease, Paris, 1973Google Scholar
  4. Deszô, I. and Fülöp, T. Die Bestimmung des Eisens und Kuffers in Blut Serum.Microchim. Acta 154 (1961) 10–17Google Scholar
  5. Henkin, R. I., Marshall, J. R. and Meren, S. Maternal-fetal metabolism of copper and zinc at term.Am. J. Obstet. Gynecol. 110 (1971) 131–137PubMedGoogle Scholar
  6. Henkins, I. R., Schulman, J. D., Schulman, C. B. and Diane, A. B. Changes in fetal, nondiffusible and diffusible plasma zinc and copper during infancy.J. Pediatr. 82(5) (1973) 831–837PubMedGoogle Scholar
  7. Mareček, Z. Wilson's disease. Dissertation (Thesis), 1980. (In Czech)Google Scholar
  8. Okinaka, S. Neurological disorders associated with disease of the liver.Reports at the 7th Congr. of Neurology, Societa Grafica Romana, Rome, 1961Google Scholar
  9. Osborn, S. B. and Walshe, J. M. Studies with radiocopper Cu64. Dynamic of copper transport.Clin. Sci. 29 (1965) 575–581PubMedGoogle Scholar
  10. Ravin, H. A. An improved colorimetric enzymatic assay of ceruloplasmin.J. Lab. Clin. Med. 58 (1961) 161–168PubMedGoogle Scholar
  11. Sternlieb, I., Morell, A. C., Bauer, Ch. D., Combes, B., De Bobes, Sternberg, S., Scheinberg, I. H. and Brosseau, J. C. Detection of the heterozygous carrier of the Wilson's disease gene.J. Clin. Invest. 40 (1961) 707–715Google Scholar
  12. Sternlieb, I. and Scheinberg, I. H. Chronic hepatitis as a first manifestation of Wilson's disease.Ann. Intern. Med. 76 (1973) 59–64Google Scholar
  13. Sternlieb, I., Van den Hemer, C. J. A., Morell, A. G., Alpert, S., Gregoriades, G. and Scheinberg, I. H. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).Gastroenterology 64 (1973) 99–105PubMedGoogle Scholar
  14. Walshe, J. M. The physiology of copper in man and its relation to Wilson's disease.Brain 90 (1967) 149–157PubMedGoogle Scholar

Copyright information

© SSIEM and MTP Press Limited 1984

Authors and Affiliations

  • Z. Mareček
    • 1
  • S. Nevšímalová
    • 1
  1. 1.Department of Neurology, 1st Department of Internal Medicine, Faculty of MedicineCharles UniversityPragueCzechoslovakia

Personalised recommendations